Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-contact infrared thermometers compared with current approaches in primary care for children aged 5 years and under: a method comparison study.
Van den Bruel A, Verbakel J, Wang K, Fleming S, Holtman G, Glogowska M, Morris E, Edwards G, Abakar Ismail F, Curtis K, Goetz J, Barnes G, Slivkova R, Nesbitt C, Aslam S, Swift E, Williams H, Hayward G. Van den Bruel A, et al. Among authors: nesbitt c. Health Technol Assess. 2020 Oct;24(53):1-28. doi: 10.3310/hta24530. Health Technol Assess. 2020. PMID: 33111663 Free PMC article.
Outcomes Following Vascular and Endovascular Procedures Performed During the First COVID-19 Pandemic Wave.
Birmpili P, Benson RA, Gwilym B, Nandhra S, Al-Saadi N, Ambler GK, Blair R, Bosanquet D, Dattani N, Hitchman L, Hurndall K, Machin M, Onida S, Saratzis A, Shalhoub J, Shelmerdine L, Singh AA; COVER Study Collaborative. Birmpili P, et al. EJVES Vasc Forum. 2024 Sep 19;62:64-71. doi: 10.1016/j.ejvsvf.2024.08.002. eCollection 2024. EJVES Vasc Forum. 2024. PMID: 39386357 Free PMC article.
Multiple sclerosis and cancer: Navigating a dual diagnosis.
Nesbitt C, Van Der Walt A, Butzkueven H, Devitt B, Jokubaitis VG. Nesbitt C, et al. Mult Scler. 2024 Dec;30(14):1714-1736. doi: 10.1177/13524585241274523. Epub 2024 Sep 30. Mult Scler. 2024. PMID: 39347791 Review.
CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective study.
Monif M, Sequeira RP, Muscat A, Stuckey S, Sanfilippo PG, Minh V, Loftus N, Voo V, Fazzolari K, Moss M, Maltby VE, Nguyen AL, Wesselingh R, Seery N, Nesbitt C, Baker J, Dwyer C, Taylor L, Rath L, Van der Walt A, Marriott M, Kalincik T, Lechner-Scott J, O'Brien TJ, Butzkueven H. Monif M, et al. Among authors: nesbitt c. Clin Immunol. 2024 Aug;265:110304. doi: 10.1016/j.clim.2024.110304. Epub 2024 Jul 2. Clin Immunol. 2024. PMID: 38964633 Clinical Trial.
Real-world efficacy, roll-out and uptake of intramuscular tixagevimab/cilgavimab as COVID-19 pre-exposure prophylaxis in people with multiple sclerosis and neuroimmunological conditions during the COVID-19 pandemic.
Rath L, Yeh WZ, Roldan A, Wesselingh R, Zhong M, Tan T, Seery N, Bridge F, Foong Y, Skibina O, Nesbitt C, Butzkueven H, Monif M, van der Walt A. Rath L, et al. Among authors: nesbitt c. BMJ Neurol Open. 2024 Apr 30;6(1):e000667. doi: 10.1136/bmjno-2024-000667. eCollection 2024. BMJ Neurol Open. 2024. PMID: 38736583 Free PMC article.
88 results